This article is mentioned in:

Introduction

The vascular endothelium is a monolayer of endothelial cells located primarily in the inner cell lining of arteries, veins and capillaries and is in direct contact with the components and cells of the blood (1,2). These cells maintain the tension and structure of blood vessels by mediating relaxation, contraction and cell proliferation inhibition and promotion (1). Furthermore, they regulate the tension of blood vessels by synthesizing and releasing vasoactive substances to regulate platelet inflammation as well as proliferation and migration of vascular smooth muscle cells (3). Endothelial cells serve an important role in the pathological progression of vascular disease (4). Endothelial cell injury can lead to arteriosclerosis and cardiovascular disease (4). Therefore, early prevention and treatment of vascular endothelial cell injury is necessary.

Previous studies have reported that autophagy serves a key role in vascular endothelial cell injury (5,6). Autophagy is a highly conserved process in which cells degrade damaged organelles and macromolecules, thereby regulating cell proliferation and development (7). Initially, cells form monolayer or bilayer membranes and then develop into vesicular autophagosomes (8). The autophagosomes fuse with lysosomes to form autolysosomes (8). Lysosomes degrade excess or damaged macromolecules and organelles in cells, recycle degradation products and maintain cell homeostasis (9). Although autophagy at the basic level has a protective effect on cells, excessive autophagy causes autophagic cell death and accelerates progression of disease (10). Autophagy is also an important means for cells to maintain iron homeostasis (11,12). Iron is an essential mineral element for the human body and excess iron levels generate a large number of hydroxyl radicals via the Fenton reaction to promote ferroptosis (12). Fe3+ binds to ferritin, including ferritin heavy chain 1 (FTH) and ferritin light chain (FTL), and stores them in cells (11). Previous studies have reported that autophagy affects iron homeostasis and promote ferroptosis by the degradation of ferritin (5,11,13). Once ferroptosis begins, vascular tissue will be damaged (5,13). For example, during ischemia-reperfusion, ferroptosis has been reported to be upregulated; specifically, the protein expression levels of cystine/glutamate antiporter solute carrier family 7 member 11 (SLC7A11; also known as xCT) and glutathione peroxidase 4 (GPX4) are decreased, glutathione (GSH) levels are decreased, reactive oxygen species (ROS) levels are increased, mitochondria are wrinkled and affected tissue is necrotic (13–15). Therefore, autophagy-dependent ferroptosis may be an important pathogenesis for vascular injury.

Fatty acid esters of 3-chloropropane-1,2-diol (3-MCPD) are chloropropanol compounds formed in food processing and storage (16). The primary source of 3-MCPD comes from acid hydrolyzed vegetable protein and byproducts in the refining of edible oil (17). 3-MCPD is classified as a potential human carcinogen by the International Agency for Research on Cancer of the World Health Organization (18). It has been reported that after 3-MCPD diester undergoes enzymatic hydrolysis in the digestive tract, 3-MCPD is released into the blood, organs and tissue (19). The kidney is reported to be the main target organ of 3-MCPD (20). 3-MCPD has also been reported to promote male infertility by inducing proteomic changes in rat testis (21). Furthermore, 3-MCPD has been reported to lead to dysfunction of the immune system and neuropathy in rats (22). To the best of our knowledge, however, whether 3-MCPD causes cardiovascular injury has not been previously reported. In the present study, the detrimental effects of 3-MCPD were evaluated in human umbilical vein endothelial cells (HUVECs). The potential underlying mechanism by which 3-MCPD induced endothelial cell injury was also assessed. To the best of our knowledge, the present study is the first to evaluate the toxic mechanism of 3-MCPD on vascular endothelial cells and may provide a scientific basis for the prevention and treatment of 3-MCPD damage, to protect human health.

Materials and methods

HUVEC culture

HUVECs were purchased from Procell Life Science & Technology Co., Ltd. and maintained in enriched culture medium (ECM; Invitrogen; Thermo Fisher Scientific, Inc.) containing 100 mg/ml streptomycin (GE Healthcare Life Sciences), 100 IU/ml penicillin (Cytiva) and 20% fetal bovine serum (FBS; HyClone; Cytiva) in a 37°C incubator containing 5% CO2.

Cell Counting Kit-8 (CCK-8) assay

To evaluate cell viability, HUVECs were seeded into 96-well plates (5×103 cells/well) and treated using 3-MCPD (MilliporeSigma) at concentrations of 0.1, 0.2, 0.4, 0.8, 1.6, 3.2 and 6.4 µg/ml for 24 h at 37°C. Then, 10 µl CCK-8 reagent (Beijing Solarbio Science & Technology Co., Ltd.) was added to each well for 4 h at 37°C. The absorbance was assessed at 450 nm using a microplate reader (Thermo Fisher Scientific, Inc.). Cell inhibition rate=(OD value of control group-OD value of experimental group)/OD value of control group ×100. The experiment was repeated three times and the half maximal inhibitory concentration (IC50) was calculated.

To assess which type of cell death was induced by 3-MCPD, HUVECs were pretreated using 1 µM ferrostatin-1 (Fer-1, ferroptosis inhibitor, MedChemExpress), 20 µM Z-VAD-FMK (pan caspase inhibitor, MedChemExpress), 10 µM Nec-1 (necrostasis inhibitor, MedChemExpress) and 10 µM 3-MA (autophagy inhibitor, MedChemExpress) at 37°C for 1 h. Cell viability was then assessed according to the aforementioned method.

EdU staining

A Cell-Light™ EdU Apollo In Vitro kit (Guangzhou RiboBio Co., Ltd.) was used to evaluate cell proliferation. Briefly, 5×103 cells were seeded in 96-well plates and incubated at 37°C overnight. Following treatment with 2 µg/ml 3-MCPD for 24 h at 37°C, the cells were incubated with 100 µl 50 µM EdU for 2 h at 37°C. After washing with PBS three times, cells were fixed using 4% paraformaldehyde (Beijing Solarbio Science & Technology Co., Ltd.) at room temperature for 10 min and then washed with PBS three times. The cells were treated using 100 µl 0.% Triton X-100 PBS at room temperature for 10 min and washed with 100 µl PBS three times. Subsequently, cells were incubated with 100 µl 1X Hoechst 33342 at room temperature for 20 min and washed with PBS three times. Finally, cells were sealed using neutral balsam (Beijing Solarbio Science & Technology Co., Ltd.) and assessed using a light microscope (magnification, ×20; Carl Zeiss AG).

Flow cytometry assay

An Annexin V-PE/7-AAD Apoptosis Detection kit (Beijing Solarbio Science & Technology Co., Ltd.) was used for flow cytometry. Briefly, HUVECs were washed using PBS and resuspended in 200 µl binding buffer at a density of 3×105 cells/ml. The cells were stained using 5 µl Annexin V/PE at room temperature for 5 min and 10 µl 20 µg/ml 7-AAD at room temperature for 5 min. Cell apoptosis [early (Q3) + late (Q2) stage apoptosis] was assessed using a FACS cytometer (BD Biosciences). The data were analyzed using FlowJo 10 software (FlowJo).

A cell cycle detection kit (BIOS Biological) was used for cell cycle analysis using flow cytometry. The cells were washed with PBS and centrifuged at 2,000 × g for 5 min at 4°C and the cell concentration was adjusted to 1×106/ml. The cell suspension was fixed using 70% ethanol at room temperature for 10 min and washed with PBS before staining using 100 µl RNase A was added at 37°C for 30 min. Then, 400 µl propidium iodide dye was added at 4°C in the dark for 30 min. Cell cycle distribution was assessed using a FACS cytometer (BD Biosciences). The data were analyzed using FlowJo 10 software (FlowJo LLC).

Assessment of oxidative stress

To assess oxidative stress, levels of malondialdehyde (MDA) and superoxide dismutase (SOD) were quantified using the Lipid Peroxidation (MDA) (cat. no. ab118970; Abcam) and SOD Assay (cat. no. ab65354; Abcam) kit, respectively, according to the manufacturer's protocols. The absorbance was assessed at 532 and 450 nm, respectively, using a Thermo Scientific™ Multiskan Sky microplate reader (Thermo Fisher Scientific, Inc.).

Senescence β-galactosidase (SA-β-gal) staining

To evaluate whether 3-MCPD induced senescence in HUVECs, SA-β-gal staining was performed using a Senescence β-Galactosidase Staining kit (Beyotime Institute of Biotechnology). Briefly, the cells were fixed using 4% paraformaldehyde (Beijing Solarbio Science & Technology Co., Ltd.) at room temperature for 10 min and washed with PBS three times. The cells were then stained using 1 ml β-galactosidase staining working solution at 37°C overnight and washed with PBS. Finally, the cells were assessed and manually quantified using an AX10 light microscope (Carl Zeiss AG; magnification, ×20). Data were presented as SA-β-gal positive cells/cells which represented the ratio of cells stained blue to all cells in each field of view manually.

Western blotting

Total protein was isolated from HUVECs using Native lysis Buffer (Beijing Solarbio Science & Technology Co., Ltd.) supplemented with Phosphatase Inhibitor Cocktail 1 (cat. no. P2850; MilliporeSigma) and cOmplete™ Protease Inhibitor Cocktail (cat. no. CO-RO; MilliporeSigma). Protein concentration quantification was performed using a BCA Protein Assay Kit (Beijing Solarbio Science & Technology Co., Ltd.). Protein (40 µg/lane) isolated from HUVECs was separated using 12% SDS-PAGE and transferred onto PVDF membranes. The membranes were blocked using 8% fat-free milk (Thermo Fisher Scientific, Inc.) at room temperature for 2 h and washed with PBS with 0.1% Tween (PBST) three times (5 min each). Membranes were incubated with primary antibodies against phosphorylated (p)-AMPK (1:1,000; cat. no. 2535; Cell Signaling Technology, Inc.), AMPK (1:1,000; cat. no. 5831; Cell Signaling Technology, Inc.), p-unc-51 like autophagy activating kinase (1:1,000; ULK1; cat. no. 37762; Cell Signaling Technology, Inc.), ULK1 (1:1,000; cat. no. 8054; Cell Signaling Technology, Inc.), p-mTOR (1:1,000; cat. no. 5536; Cell Signaling Technology, Inc.), mTOR (1:1,000; cat. no. 2983; Cell Signaling Technology, Inc.), p53 (1:1,000; cat. no. 2527; Cell Signaling Technology, Inc.), p16 (1:1,000; cat. no. 18769; Cell Signaling Technology, Inc.), p21 (1:1,000; cat. no. 2947; Cell Signaling Technology, Inc.), light chain (LC)3II/I (1:1,000; cat. no. 3868; Cell Signaling Technology, Inc.), p62 (1:1,000; cat. no. 88588; Cell Signaling Technology, Inc.), GPX4 (1:1,000; cat. no. 59735; Cell Signaling Technology, Inc.), SLC7A11 (1:1,000; cat. no. 12691; Cell Signaling Technology, Inc.), FTH1 (1:1,000; cat. no. 4393; Cell Signaling Technology, Inc.) and GAPDH (1:4,000; cat. no. 5174; Cell Signaling Technology, Inc.) at 4°C overnight. After washing with PBST three times, membranes were incubated with goat anti-rabbit IgG/horseradish peroxidase (1:3,000; cat. no. SE134, Beijing Solarbio Science & Technology Co., Ltd.) or goat anti-mouse IgG/horseradish peroxidase (1:3,000; cat. no. SE131, Beijing Solarbio Science & Technology Co., Ltd.) at room temperature for 2 h. After washing with PBST three times (5 min each), proteins were assessed using an ECL Western Blotting Substrate (cat. no. PE0010, Beijing Solarbio Science & Technology Co., Ltd.). The relative density of the protein bands was semi-quantified using ImageJ 7.1 software (National Institutes of Health) and GAPDH was used as an internal control.

Transmission electron microscope assay

HUVECs were fixed using 2.5% glutaraldehyde at room temperature for 2 h and post-fixed using 1% osmium tetroxide with 0.1% potassium ferricyanide at room temperature for 2 h. Following dehydration via a graded ethanol series (50–100%), the HUVEC samples were embedded in epoxy resin. Next, the samples were cut into 60 nm ultrathin sections at this stage using a Leica EM UC7 ultramicrotome. Subsequently, ultrathin sections were stained using 2% uranyl acetate saturated alcohol solution at room temperature for 30 min and lead citrate at room temperature for 30 min. Images were captured using a Hitachi-HT7700 transmission electron microscope (magnification, ×7,000).

Autophagic flux analysis

GFP-LC3-mCherry adenovirus vectors were purchased from HanBiotechnology Co., Ltd. To evaluate autophagic flux in vitro, HUVECs were transduced with ad-GFP-LC3-mCherry at a multiplicity of infection of 30 for 24 h at 37°C. After treatment with 2.0 µg/ml 3-MCPD for 24 h or untreated blank control, autophagic flux was assessed using a laser confocal microscope (magnification, ×400; Carl Zeiss AG). A red puncta (mCherry+/GFP-) indicated the formation of autolysosomes, whereas a yellow puncta (mCherry+/GFP+) indicated the accumulation of autophagosomes.

Assessment of lipid peroxidation

HUVECs were seeded into 6-well plates (1×106 cells/well) and treated with 2.0 µg/ml 3-MCPD (MilliporeSigma) or untreated control cells for 24 h at 37°C. The cells were treated using 2 µM C11-BODIPY581/591 (lipid peroxidation) (Invitrogen; Thermo Fisher Scientific, Inc.) for 30 min at 37°C in the dark. The cells were washed with PBS to remove the unincorporated dye and evaluated using a fluorescence microscope (magnification, ×400; Carl Zeiss AG).

Immunofluorescence (IF)

A DNA damage detection kit [γ-H2A histone family member X (γ-H2AX) immunofluorescence method] (cat. no. C2035S; Beyotime Institute of Biotechnology) was used to evaluate DNA damage in HUVECs treated with 2.0 µg/ml 3-MCPD or control at 37°C for 24 h. Briefly, cells were fixed using 4% paraformaldehyde (Beijing Solarbio Science & Technology Co., Ltd.) at room temperature for 10 min and washed using PBS three times. The cells were blocked using 5% non-fat milk (Thermo Fisher Scientific, Inc.) at room temperature for 2 h. The cells were incubated with primary antibodies against γ-H2AX (1:50; C2035S; Beyotime Institute of Biotechnology) or AMPK (1:50; cat. no. 5831; Cell Signaling Technology, Inc.) at 4°C overnight and washed with PBST three times. Subsequently, cells were further incubated with Goat anti-Rabbit IgG/FITC (cat. no. SF134; Beijing Solarbio Science & Technology Co., Ltd.) at room temperature for 1 h and washed using PBST for 5 min at room temperature. Finally, 1 ml DAPI was added to each well at room temperature for 5 min and washed with PBS for 5 min. The cells were observed using a fluorescence microscope (magnification, 20×; Carl Zeiss AG).

Determination of mitochondrial membrane potential (MMP)

To evaluate MMP of HUVECs, a JC-1-Mitochondrial Potential Assay kit (Abcam) was used according to the manufacturer's protocols. Briefly, the cells were incubated with JC-1 solution for 10 min at 37°C. Then, the cells were washed with 1 ml dilution buffer three times and assessed using a fluorescence microscope (magnification, ×20; Carl Zeiss AG).

FerroOrange staining

A FerroOrange (Fe2+ indicator) probe (cat. no. MX4559; Shanghai Maokang Biotechnology Co., Ltd.) was used to assess intracellular Fe2+ levels according to the manufacturer's protocol. Briefly, cells were incubated with 1 µM FerroOrange for 30 min at 37°C. The cells were assessed using a fluorescence microscope (magnification, ×20; Carl Zeiss AG).

Transient transfection

Transient transfection was performed using HiPerFect Transfection Reagent (Qiagen GmbH). Briefly, HUVECs were cultured in 6-well plates at a density of 5×105 cells/well overnight at 37°C. A small interfering RNA (siRNA) targeting AMPK (siAMPK; Shanghai GenePharma Co., Ltd.) or negative control (NC; Shanghai GenePharma Co., Ltd.) was diluted with ECM without FBS to a concentration of 100 nM and mixed with 12 µl HiPerFect Transfection Reagent at room temperature for 10 min. The mixture was added into each well and incubated at 37°C for 48 h. The cells were then collected for immediate use in subsequent experiments. The sequences used for the siRNAs were as follows: NC, 5′-UUCUCCGAACGUGUCACGUTT-3′ and siAMPK, 5′-UUUCAGGCAUCCUCAUAUAAU-3′.

Statistical analysis

Data are presented as the mean ± standard deviation. Statistical analysis was performed using GraphPad Prism 7 (GraphPad Software, Inc.). Unpaired Student's t test or one way analysis of variance followed by Tukey's post hoc test were used between two groups or among multiple groups, respectively, to analyze statistical significance. All data were obtained from three independent repeats. P<0.05 was considered to indicate a statistically significant difference.

Results

3-MCDP suppresses HUVEC proliferation and induces cell cycle arrest

HUVECs were treated using 3-MCPD and cell viability was assessed. The CCK-8 assay demonstrated that 3-MCPD significantly decreased HUVEC viability in a dose-dependent manner compared with the control and the IC50 of 3-MCPD was 2.03 µg/ml (Fig. 1A). EdU staining demonstrated that 3-MCPD treatment significantly decreased the proliferation of HUVECs compared with the control (Fig. 1B). Furthermore, 3-MCPD treatment promoted cell cycle arrest, as demonstrated by a significant elevation in G0-G1 cell population and a significant decrease in the S phase cell population (Fig. 1C).

Figure 1. 3-MCDP suppresses HUVEC proliferation and induces cell cycle arrest. (A) Cell Counting Kit-8 assay demonstrated that 3-MCPD significantly decreased HUVEC viability in a dose-dependent manner. Cell viability was normalized to the untreated Con. (B) EdU staining demonstrated that 3-MCPD significantly suppressed HUVEC proliferation (scale bar, 10 µm). (C) Flow cytometry demonstrated that 3-MCPD induced HUVEC cycle arrest. *P<0.05, **P<0.01 and ***P<0.001 vs. Con. 3-MCPD, 3-Chloropropane-1,2-diol; HUVEC, human umbilical vein endothelial cell; EdU, 5-ethynyl-2′-deoxyuridine; Con, control; OD, optical density; IC50, half maximal inhibitory concentration.

3-MCPD induces senescence and death in HUVECs

SA-β-gal staining demonstrated that 3-MCPD significantly increased the number of SA-β-gal-positive cells compared with the control (Fig. 2A). DNA damage assay demonstrated that 3-MCPD markedly elevated the relative fluorescence of γ-H2AX (Fig. 2B). Moreover, 3-MCPD significantly increased the proportion of dead HUVECs compared with the control (Fig. 2C). The expression levels of senescence-associated proteins, including p53, p21 and p16, were semi-quantified. These data demonstrated that 3-MCPD significantly enhanced the protein expression levels of p53, p21 and p16 compared with the control (Fig. 2D).

Figure 2. 3-MCPD induces senescence and death in HUVECs. (A) SA-β-gal staining demonstrated that 3-MCPD significantly increased the number of SA-β-gal-positive cells compared with the Con (scale bar, 10 µm). (B) Immunofluorescence staining demonstrated that 3-MCPD markedly elevated the relative fluorescence of γ-H2AX (scale bar, 10 µm). (C) Flow cytometry demonstrated that 3-MCPD significantly increased the proportion of dead HUVECs compared with Con. (D) Western blotting demonstrated that 3-MCPD significantly enhanced protein expression levels of p53, p21 and p16 compared with Con. *P<0.05, **P<0.01 and ***P<0.001 vs. Con. 3-MCPD, 3-Chloropropane-1,2-diol; HUVEC, human umbilical vein endothelial cell; SA-β-gal, senescence β-galactosidase; Con, control; γ-H2AX, γ-H2A histone family member X.

3-MCPD promotes ferroptosis and autophagy in HUVECs

HUVECs were treated with 2.0 µg/ml 3-MCPD for 12, 24, 48 and 72 h. CCK-8 assay demonstrated that 3-MCPD significantly decreased HUVEC viability in a time-dependent manner compared with the control (Fig. 3A). Furthermore, CCK-8 assay demonstrated that 3-MCPD-induced cell death was significantly decreased by Fer-1 and 3-MA preincubation compared with the control (Fig. 3B). These data demonstrated that 3-MCPD may promote cell death by inducing ferroptosis and autophagy.

Figure 3. 3-MCPD promotes ferroptosis and autophagy in HUVECs. (A) Cell Counting Kit-8 assay demonstrated that 3-MCPD significantly decreased HUVEC viability in a time-dependent manner. (B) 3-MCPD induced cell death was reversed by preincubation with Fer-1 and 3-MA. **P<0.01 and ***P<0.001 vs. Con; ##P<0.01 vs. 3-MCPD. 3-MCPD, 3-Chloropropane-1,2-diol; HUVEC, human umbilical vein endothelial cell; Fer-1, ferrostatin-1; Con, control; OD, optical density.

3-MA abolishes 3-MCPD-induced autophagy

TEM analysis demonstrated rupture of the mitochondrial membrane and disappearance of the mitochondrial ridge in HUVECs treated with 3-MCPD (Fig. 4A). Whether 3-MCPD activated autophagic flux in HUVECs was evaluated. 3-MCPD significantly enhanced formation of autolysosomes compared with the control, whereas 3-MA preincubation significantly decreased the number of autolysosomes in HUVECs compared with the 3-MCPD group (Fig. 4B). Furthermore, 3-MCPD significantly increased the protein expression level ratio of LC3II to LC3I and significantly decreased protein expression levels of p62 in HUVECs compared with the control (Fig. 4C). However, preincubation with 3-MA significantly decreased the ratio of LC3II/LCI protein expression and significantly elevated protein expression levels of p62 in HUVEC compared with the 3-MCPD group (Fig. 4C). These data demonstrated that 3-MCPD activated autophagic flux in HUVECs.

Figure 4. 3-MA autophagy inhibitor abolishes 3-MCPD-induced autophagy. (A) Transmission electron microscopy demonstrated rupture of the mitochondrial membrane and disappearance of the mitochondrial ridge (scale bar, 1 µm). (B) Fluorescence microscopy demonstrated that 3-MCPD significantly enhanced the number of red puncta, whereas 3-MA preincubation decreased the number of red puncta in HUVECs (scale bar, 10 µm). (C) Western blotting demonstrated that 3-MCPD significantly increased the ratio of LC3II and LC3I but decreased protein expression levels of p62 in HUVECs. **P<0.01 and ***P<0.001 vs. Con; ##P<0.01 and ###P<0.001 vs. 3-MCPD. 3-MCPD, 3-Chloropropane-1,2-diol; HUVEC, human umbilical vein endothelial cell; Con, control; LC, light chain; M, mitochondria.

Fer-1 reverses 3-MCPD-induced ferroptosis

MMP is an important indicator of mitochondrial function (23). 3-MCPD markedly increased MMP, as demonstrated by the elevated ratio of JC-1/poly JC-1. However, preincubation with Fer-1 markedly restored the mono JC-1/poly JC-1 ratio in HUVECs (Fig. 5A). 3-MCPD also markedly induced accumulation of Fe2+ and lipid ROS compared with the control, whereas preincubation with Fer-1 markedly diminished these effects compared with the 3-MCPD group (Fig. 5B and C). Furthermore, 3-MCPD significantly increased accumulation of SOD and MDA in HUVECs compared with the control; however, Fer-1 significantly neutralized these effects (Fig. 5D). The expression levels of ferroptosis-associated proteins, including GPX4, SLC7A11 and FTH1, were significantly decreased by 3-MCPD in HUVECs compared with the control (Fig. 5E). However, preincubation with Fer-1 significantly elevated the protein expression levels of GPX4, SLC7A11 and FTH1 in HUVECs compared with the 3-MCPD group (Fig. 5E).

Figure 5. Fer-1 reverses 3-MCPD-induced ferroptosis in HUVECs. (A) Assessment of mitochondrial membrane potential in HUVECs treated with 3-MCPD (scale bar, 10 µm). (B) FerroOrange staining demonstrated that 3-MCPD markedly elevated intracellular Fe2+ levels in HUVECs (scale bar, 10 µm). (C) C11-BODIPY581/591 staining demonstrated that 3-MCPD markedly enhanced accumulation of lipid reactive oxygen species in HUVECs (scale bar, 10 µm). (D) 3-MCPD significantly increased the accumulation of SOD and MDA in HUVECs; Fer-1 partially neutralized these effects. (E) 3-MCPD significantly decreased expression levels of ferroptosis-related proteins, including GPX4, SLC7A11 and FTH1, in HUVECs. *P<0.05, **P<0.01 and ***P<0.001 vs. Con; #P<0.05 and ##P<0.01 vs. 3-MCPD. 3-MCPD, 3-Chloropropane-1,2-diol; HUVEC, human umbilical vein endothelial cell; Fer-1, ferrostatin-1; GPX4, glutathione peroxidase; 4SLC7A11, cystine/glutamate antiporter solute carrier family 7 member 11; SOD, superoxide dismutase; MDA, malondialdehyde; Con, control.

3-MCPD induces autophagy and ferroptosis via activation of AMPK signaling

AMPK/ULK1/mTOR signaling serves a key role in autophagy and ferroptosis (24,25). Therefore, activation of AMPK/ULK1/mTOR signaling in HUVECs treated with 3-MCPD was evaluated. The data demonstrated that 3-MCPD significantly increased phosphorylation of AMPK and ULK1 but significantly decreased phosphorylation of mTOR in HUVECs compared with the control at 24 and 48 h (Fig. 6A). To evaluate whether 3-MCPD induced autophagy and ferroptosis via AMPK signaling, a specific siRNA targeting AMPK was used. IF staining demonstrated that transfection with siAMPK markedly suppressed the relative fluorescence of AMPK even in the presence of 3-MCPD (Fig. 6B). Western blotting demonstrated that transfection with siAMPK significantly knocked down AMPK protein expression levels in HUVECs compared with those transfected with NC (Fig. 6C). TEM demonstrated that 3-MCPD-induced mitochondrial swelling and rupture of the mitochondrial ridge was markedly decreased by siAMPK (Fig. 6D). Furthermore, 3-MPCD-induced autophagy was markedly alleviated by siAMPK transfection (Fig. 6E). Moreover, the 3-MCPD-induced accumulation of Fe2+ and lipid ROS was markedly decreased by silencing AMPK (Fig. 6F and G). These data demonstrated that 3-MCPD induced autophagy and ferroptosis via activation of AMPK signaling.

Figure 6. 3-MCPD induces autophagy and ferroptosis via activation of AMPK signaling. (A) Western blotting demonstrated that 3-MCPD significantly increased phosphorylation of AMPK and ULK1 and significantly decreased the phosphorylation of mTOR in HUVECs at 24 and 48 h. (B) Immunofluorescence staining demonstrated that transfection with siAMPK markedly suppressed the relative fluorescence of AMPK even in the presence of 3-MCPD (scale bar, 10 µm). (C) Western blotting demonstrated that transfection with siAMPK significantly knocked down AMPK expression in HUVECs compared with those transfected with NC. (D) Transmission electron microscopy demonstrated that 3-MCPD-induced mitochondrial swelling and rupture of the mitochondrial ridge was prevented by siAMPK (scale bar, 1 µm). (E) 3-MPCD-induced autophagy was alleviated by siAMPK transfection (scale bar, 10 µm). (F) 3-MCPD-induced accumulation of Fe2+ (scale bar, 10 µm) and (G) lipid ROS were decreased by silencing AMPK (scale bar, 10 µm). *P<0.01 and **P<0.01 vs. Con. ##P<0.01 vs. 3-MCPD. 3-MCPD, 3-Chloropropane-1,2-diol; HUVEC, human umbilical vein endothelial cell; ULK1, unc-51 like autophagy activating kinase; si, small interfering RNA; NC, negative control; Con, control; p-, phosphorylated.

Discussion

3-MCPD is an internationally recognized food pollutant and its formation is associated with processing of acid hydrolyzed plant protein (18). The raw material for acid hydrolyzed vegetable protein is typically soybean or rapeseed meal (18). Under high temperatures, hydrochloric acid reacts with glycerol, which is hydrolyzed by triglycerides to form 3-MCPD (26). 3-MCPD has reproductive, renal and neurotoxic effects and may also have carcinogenic and mutagenic effects (26). To the best of our knowledge, however, whether 3-MCDP induces cell damage via ferroptosis in HUVECs has not been previously reported. The present study demonstrated that 3-MCPD significantly inhibited HUVEC proliferation in a dose-dependent manner and significantly induced cell cycle arrest. 3-MCPD also induced senescence in HUVECs with increased DNA damage and cell death. Furthermore, protein markers associated with cell aging were detected and it was demonstrated that 3-MCPD significantly increased p53, p21 and p16 protein expression levels. These results suggested that 3-MCPD induced HUVEC injury.

The type of cell death triggered by 3-MCPD in HUVECs was evaluated. The CCK-8 results demonstrated that pretreatment with a ferroptosis or autophagy inhibitor significantly decreased cell death induced by 3-MCPD. Autophagic cell death is type II programmed cell death, which is different from apoptosis and is another key death regulation mechanism (27). Autophagic cell death is characterized by massive degradation of basic organelles, such as mitochondria, through complex endo-cellular/vesicular remodeling and lysosomal activation mechanisms (27). Using TEM and mCherry-GFP-LC3B double label system analysis, it was demonstrated that 3-MCPD induced a significant increase in the number of autolysosomes in HUVECs and that the autophagy inhibitor 3-MA significantly reversed this result. The expression levels of marker proteins of autophagic flux, such as LC3II and p62, were assessed. It was demonstrated that 3-MCPD significantly increased protein expression of LC3II and significantly decreased protein expression of p62 in HUVECs. However, 3-MA treatment significantly reversed these effects. These results demonstrated that sustained autophagic flux was involved in the death of HUVECs caused by 3-MCPD.

Ferroptosis is characterized morphologically by an intact cytosol, decreased or absent mitochondria and a ruptured outer mitochondrial membrane with a normal nucleus and no chromosome condensation (23). In the present study, 3-MCPD markedly increased the MMP, which indicated induction of mitochondrial dysfunction by 3-MCPD. The System Xc-/GPX4 signaling pathway is one of the primary pathways of ferroptosis (28). GPX4 converts intracellular GSH into oxidized glutathione and converts intracellular toxic lipid hydrogen peroxide into cysteine (29). GSH is the primary endogenous antioxidant and inhibition of intracellular System Xc-/GPX4 leads to a decrease in GSH and thus induces ferroptosis (29). Furthermore, circulating iron, bound in transferrin, enters the cell via the transferrin receptor 1 on the membrane (30). In the endosome, iron reductase reduces Fe3+ to Fe2+ (30). Finally, divalent metal transporter 1 (also known as SLC11A2) mediates release of Fe2+ from the endosome into the labile iron pool and excess iron is stored in ferritin (such as FTL and FTH1) (31). The imbalance of intracellular iron ions leads to ferroptosis (31). In the present study, 3-MCPD markedly increased intracellular iron ion levels and lipid peroxidation in HUVECs. Furthermore, the protein expression levels of GPX4, SLC7A11 and FTH1 were decreased by 3-MCPD treatment, whereas the ferroptosis inhibitor fer-1 reversed this effect. Therefore, it could be hypothesized that 3-MCPD caused ferroptosis in HUVECs by inducing lipid peroxidation and imbalance of ferric ion homeostasis.

mTOR and AMPK are two of the classical autophagic signaling regulatory pathways (32,33). mTOR is a negative regulatory pathway of autophagy and when p-mTOR levels are elevated, it causes a decrease in p-ULK1, which activates its downstream substrate molecules, such as p-EIF4EBP1 and p-RPS6KB1/p70 S6 kinase, and inhibits autophagy (32). However, AMPK is a positive regulatory signal of autophagy; when p-AMPK is activated, it suppresses p-mTOR and elevates p-ULK1 protein expression levels, which activates autophagy via key autophagy-associated proteins such as BECN1, ATG5 and ATG7 (33). It has been reported that activation of autophagy by the AMPK/mTOR/ULK1 signaling pathway promotes ferroptosis (5,34). In autophagy, nuclear receptor coactivator 4, an important transporter of lysosomes, regulates intracellular iron homeostasis and thus ferroptosis by binding to ferritin and mediating ferritin transport to lysosomes for degradation (5). Furthermore, AMPK also promotes ferroptosis by inhibition of System Xc-activity (35,36). The possible molecular mechanism is that AMPK phosphorylates BECN1 at the S90/93/96 sites, which contributes to the formation of the BECN1-SLC7A11 complex and induces increased lipid peroxidation and ferroptosis (35). Therefore, the present study evaluated whether 3-MCPD caused autophagy and ferroptosis in HUVECs via AMPK/mTOR/ULK1 signaling. The present study demonstrated that following 3-MCPD treatment, the phosphorylation levels of AMPK and ULK1 increased significantly, while phosphorylation of mTOR was significantly decreased in HUVECs. To assess whether 3-MCPD affected autophagy and ferroptosis via AMPK signaling, a specific siRNA targeting AMPK was used. The results demonstrated that silencing AMPK significantly reversed the increase in autophagy, lipid peroxidation and Fe2+ induced by 3-MCPD. These results suggested that 3-MCPD regulated autophagy and ferroptosis in HUVECs via the AMPK/mTOR/ULK1 signaling pathway.

The cytotoxicity of 3-MCPD has been widely reported in different systems (21,37–39). For example, 3-MCPD has been reported to trigger the death of 293 cells via the death receptor and the mitochondrial pathway (37). Furthermore, 3-MCPD has been reported to induce apoptosis in rat brain cells via activation of caspase 3 (38). In Wistar rats, 3-MCPD has been reported to inhibit glucose metabolism by the induction of glutamate S-transfer π 1, which leads to nephrotoxicity (39). Furthermore, in the early stage of rat testis injury, 3-MCPD is reported to have affected the reproductive function of rats by the inhibition of glycolysis to induce comprehensive changes in reproductive-associated protein (21). Compared with the aforementioned results, the results of the present study demonstrated for the first time that 3-MCPD caused HUVEC damage and that the specific mechanism was activation of AMPK signaling to cause autophagy and ferroptosis. This result expanded understanding of 3-MCPD cytotoxicity and suggested that 3-MCPD may mediate vascular injury by causing cell death.

However, there are limitations in the present study. Firstly, the mechanism of 3-MCPD damage in vascular endothelial injury was not assessed using in vivo experiments. Secondly, whether 3-MCPD triggered ferroptosis through other mechanisms requires further investigation.

In conclusion, 3-MCPD damaged HUVECs via induction of autophagy and ferroptosis; such effects may be mediated via the AMPK/mTOR/ULK1 signaling pathway. However, it is not clear whether 3-MCPD causes vascular injury via other signaling pathways.

Acknowledgements

Not applicable.

Funding

The present study was supported by The Natural Science Foundation of Hebei Province (grant no. 86752315).

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

XY performed the experiments and analyzed the data. XL performed the western blotting. XY and CL designed the experiments, analyzed the data and gave final approval of the version to be published. All authors have read and approved the final manuscript. XY and CL confirm the authenticity of all the raw data.

Ethics approval and consent to participate

Not applicable.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References